These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21039640)

  • 1. Utility of postoperative testing of implantable cardioverter-defibrillators.
    Sauer WH; Lowery CM; Bargas RL; Schuller JL; Stees CS; Aleong RG; Varosy PD
    Pacing Clin Electrophysiol; 2011 Feb; 34(2):186-92. PubMed ID: 21039640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defibrillation testing: philosophy and science.
    Fisher JD
    Pacing Clin Electrophysiol; 2011 Feb; 34(2):185. PubMed ID: 21138446
    [No Abstract]   [Full Text] [Related]  

  • 3. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of implantable cardioverter defibrillator avoiding routine defibrillation threshold testing].
    Liu Q; Zhou S; Qi S; Zeng G; Ma X; Huang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1132-5. PubMed ID: 19952404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®.
    Russo AM; Wang Y; Al-Khatib SM; Curtis JP; Lampert R
    Pacing Clin Electrophysiol; 2013 Dec; 36(12):1522-31. PubMed ID: 23981009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undersensing of ventricular fibrillation due to interference between a pacemaker and defibrillator in the same patient.
    Van Casteren L; Huybrechts W; Willems R
    Europace; 2009 Oct; 11(10):1390-1. PubMed ID: 19654130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of routine follow-up defibrillator threshold testing in congenital heart disease and pediatric populations.
    Stephenson EA; Cecchin F; Walsh EP; Berul CI
    J Cardiovasc Electrophysiol; 2005 Jan; 16(1):69-73. PubMed ID: 15673391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
    Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
    Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of treatment effectiveness of implantable cardioverter defibrillator in patients undergoing defibrillation threshold testing at the time of implantation versus no defibrillation threshold testing].
    Lelakowski J; Tomala I; Rydlewska A; Majewski J; Kuniewicz M; Małecka B
    Pol Merkur Lekarski; 2010 Sep; 29(171):153-6. PubMed ID: 20931822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?
    Calvi V; Dugo D; Capodanno D; Arancio R; Di Grazia A; Liotta C; Puzzangara E; Ragusa A; Arestia A; Tamburino C
    Am Heart J; 2010 Jan; 159(1):98-102. PubMed ID: 20102873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac implantable electronic device reutilization: battery life of explanted devices at a tertiary care center.
    Gakenheimer L; Romero J; Baman TS; Montgomery D; Smith CA; Oral H; Eagle KA; Crawford T
    Pacing Clin Electrophysiol; 2014 May; 37(5):569-75. PubMed ID: 24359248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with transvenous implantable cardioverter-defibrillators for treatment of malignant ventricular arrhythmias.
    Jadonath RL; Pogo GJ; Goldner BG; Kalenderian D; Merkatz K; Cohen MB; Snow JS; Cohen TJ
    J Invasive Cardiol; 1995 Apr; 7(3):72-9. PubMed ID: 10155366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis.
    Stavrakis S; Patel NH; Reynolds DW
    Pacing Clin Electrophysiol; 2013 Nov; 36(11):1402-8. PubMed ID: 23875736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of implantable defibrillator longevity under clinical circumstances: implications for device selection.
    Knops P; Theuns DA; Res JC; Jordaens L
    Pacing Clin Electrophysiol; 2009 Oct; 32(10):1276-85. PubMed ID: 19796344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up.
    Bianchi S; Ricci RP; Biscione F; Sgreccia F; Di Belardino N; Rossi P; Giuli S; Grammatico A; De Santo T; Santi E; Merico M; Piccirillo G; Azzolini P; Santini M; Puglisi A
    Pacing Clin Electrophysiol; 2009 May; 32(5):573-8. PubMed ID: 19422577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a need for routine testing of ICD defibrillation capacity? Results from more than 1000 studies.
    Brunn J; Böcker D; Weber M; Castrucci M; Gradaus R; Borggrefe M; Breithardt G; Block M
    Eur Heart J; 2000 Jan; 21(2):162-9. PubMed ID: 10637090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mobile telephones on the function of implantable cardioverter defibrillators.
    Tandogan I; Ozin B; Bozbas H; Turhan S; Ozdemir R; Yetkin E; Topal E
    Ann Noninvasive Electrocardiol; 2005 Oct; 10(4):409-13. PubMed ID: 16255750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.